Bing Wei

862 total citations
33 papers, 622 citations indexed

About

Bing Wei is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bing Wei has authored 33 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bing Wei's work include RNA modifications and cancer (11 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Bing Wei is often cited by papers focused on RNA modifications and cancer (11 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Bing Wei collaborates with scholars based in China, Netherlands and Australia. Bing Wei's co-authors include Lei Zhan, Jie Ma, Yongjun Guo, Xiuying Tang, Pengfei Ren, Lin Shi, Jianguang Qi, Lin Zou, Lan Zeng and Fen Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Scientific Reports.

In The Last Decade

Bing Wei

29 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Wei China 15 408 283 77 74 64 33 622
Hai-Yu Mo China 8 285 0.7× 187 0.7× 53 0.7× 21 0.3× 104 1.6× 10 454
Valerio Ciccone Italy 16 242 0.6× 128 0.5× 72 0.9× 71 1.0× 145 2.3× 44 618
Peiyan Hua China 15 367 0.9× 199 0.7× 65 0.8× 46 0.6× 87 1.4× 31 560
Andrea E. Calvert United States 10 257 0.6× 167 0.6× 148 1.9× 34 0.5× 44 0.7× 17 460
Jianjie Qin China 15 400 1.0× 268 0.9× 39 0.5× 29 0.4× 78 1.2× 21 695
Wenjie Zhang China 17 407 1.0× 193 0.7× 115 1.5× 15 0.2× 120 1.9× 47 649
Aparna Maiti United States 16 494 1.2× 136 0.5× 76 1.0× 19 0.3× 135 2.1× 25 759
Ainhoa Iglesias–Ara Spain 16 536 1.3× 156 0.6× 18 0.2× 51 0.7× 122 1.9× 26 846
Marilena Castelli Italy 14 229 0.6× 88 0.3× 32 0.4× 35 0.5× 83 1.3× 23 413
Xiufeng Yu China 20 559 1.4× 353 1.2× 368 4.8× 60 0.8× 68 1.1× 35 873

Countries citing papers authored by Bing Wei

Since Specialization
Citations

This map shows the geographic impact of Bing Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Wei more than expected).

Fields of papers citing papers by Bing Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Wei. The network helps show where Bing Wei may publish in the future.

Co-authorship network of co-authors of Bing Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Wei. A scholar is included among the top collaborators of Bing Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Wei. Bing Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Tao, et al.. (2025). Uncovering global research frontiers in deubiquitinating enzymes and immunotherapy: A bibliometric study. Human Vaccines & Immunotherapeutics. 21(1). 2483558–2483558.
2.
Zhang, Chengjuan, Ruihua Bai, Yanping Hu, et al.. (2025). Heterogeneity and distribution characteristics of tertiary lymphoid structures predict prognostic outcome in esophageal squamous cell carcinoma. Frontiers in Immunology. 16. 1606499–1606499. 1 indexed citations
3.
Ke, Yang, Jiuzhou Zhao, Tingjie Wang, et al.. (2025). Clinical application of targeted next-generation sequencing in pneumonia diagnosis among cancer patients. Frontiers in Cellular and Infection Microbiology. 15. 1497198–1497198. 1 indexed citations
4.
Wei, Tao, et al.. (2025). Mapping the future: bibliometric insights into ferroptosis and diabetic nephropathy. Frontiers in Physiology. 16. 1516466–1516466.
5.
Li, Jun, Cuiyun Zhang, Siyu Wang, et al.. (2024). Profiling of driver mutations in lung adenocarcinoma patients identifies rare compound EGFR mutations sensitive to second-generation EGFR-TKIs. SHILAP Revista de lepidopterología. 3(1).
6.
Wang, Haihong, Wei Wu, Yunfei Li, et al.. (2023). Circulating cell-free DNA fragmentation is a stepwise and conserved process linked to apoptosis. BMC Biology. 21(1). 253–253. 17 indexed citations
7.
Chen, Jiahua, Xiaojing Liu, Jing Zhang, et al.. (2022). Roles of N6-methyladenosine (m6A) modifications in gynecologic cancers: mechanisms and therapeutic targeting. Experimental Hematology and Oncology. 11(1). 98–98. 5 indexed citations
8.
Wei, Bing, et al.. (2022). M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy. Frontiers in Pharmacology. 13. 1052177–1052177. 4 indexed citations
9.
Li, Jun, Cuiyun Zhang, Yanlin Luo, et al.. (2021). Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients. Frontiers in Oncology. 11. 655709–655709. 5 indexed citations
10.
Wei, Bing, Haibo Sun, Chi Yan, et al.. (2021). A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer. Scientific Reports. 11(1). 16782–16782. 34 indexed citations
11.
Gao, Ming, et al.. (2021). Upregulation of MicroRNA-34a Sensitizes Ovarian Cancer Cells to Resveratrol by Targeting Bcl-2. Yonsei Medical Journal. 62(8). 691–691. 25 indexed citations
12.
Liu, Yisong & Bing Wei. (2019). Over-expression of Bcl2-associated athanogene 2 in oral cancer promotes cellular proliferation and is associated with poor prognosis. Archives of Oral Biology. 102. 164–170. 12 indexed citations
13.
14.
Jiao, Ying, Bing Wei, Kuo-Wei Tseng, et al.. (2018). Protein supplementation enhances cerebral oxygenation during exercise in elite basketball players. Nutrition. 53. 34–37. 8 indexed citations
15.
Wang, Wenyan, Yunxia Cao, Xiao Zhou, et al.. (2018). PTP1B promotes the malignancy of ovarian cancer cells in a JNK-dependent mechanism. Biochemical and Biophysical Research Communications. 503(2). 903–909. 14 indexed citations
16.
Zhan, Lei, et al.. (2018). Long non-coding RNAs in ovarian cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 120–120. 71 indexed citations
17.
Mo, Minli, Jie Ma, Chen Zhao, et al.. (2014). Measurement of genome-wide DNA methylation predicts survival benefits from chemotherapy in non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 141(5). 901–908. 1 indexed citations
18.
Zeng, Lan, Yi‐Ming Chen, Lin Zou, et al.. (2014). Naringin inhibits growth and induces apoptosis by a mechanism dependent on reduced activation of NF-κB/COX-2-caspase-1 pathway in HeLa cervical cancer cells. International Journal of Oncology. 45(5). 1929–1936. 69 indexed citations
19.
Gao, Jingchun, Yi Zhao, Bing Wei, et al.. (2013). Mirk/Dyrk1B mediates G0/G1 to S phase cell cycle progression and cell survival involving MAPK/ERK signaling in human cancer cells. Cancer Cell International. 13(1). 2–2. 43 indexed citations
20.
Shi, Lin, Junbao Du, Jianguang Qi, et al.. (2003). [Effects of high pulmonary blood flow on pulmonary vascular structure and the gene expression of cystathionine-gamma-lyase].. PubMed. 35(6). 566–70. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hai-Yu Mo Breakdown of academic impact, for papers by Valerio Ciccone Breakdown of academic impact, for papers by Peiyan Hua Breakdown of academic impact, for papers by Andrea E. Calvert Breakdown of academic impact, for papers by Jianjie Qin Breakdown of academic impact, for papers by Wenjie Zhang Breakdown of academic impact, for papers by Aparna Maiti Breakdown of academic impact, for papers by Ainhoa Iglesias–Ara Breakdown of academic impact, for papers by Marilena Castelli Breakdown of academic impact, for papers by Xiufeng Yu
Rankless by CCL
2026